Login

Controversial Role of LLMs in Medical Manuscript Writing - Dr. Pablo Moreno Franco 00:00:00

Share On Facebook Share On Twitter

Controversial Role of LLMs in Medical Manuscript Writing

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Vision and Future Strategies of Convergenze SpA: Insights from CEO Rosario Pingaro | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Investment Thesis and Community Engagement of NovaGold's Donlin Gold Property
00:10:00
Frank Tang on China's Path to Post-COVID Recovery and Business Resilience | Frank Tang, CEO, FountainVest Partners.
00:10:00
Key Considerations When Choosing a Financial Advisor
00:10:00
Making New Friends in Your 50s: Tips from Nicole and Ron | Ron Bernstein, Co-founder , Prism Planning Partners.
00:10:00
Integrating ESG: How Lazard Embeds Sustainability in Fundamental Analysis
00:10:00
Schwab's CEO Walt Bettinger on Disruption, Trust, and Future Challenges | Walter W Bettinger II, CEO, Charles Schwab Corporation.
00:10:00
Future Food: Lab to Farm to Fork | Marcus Pöllinger - CEO of BayWa
00:10:00
Denver Wealth Management Practice | Aspen Wealth Strategies | ANDY MCCLAFLIN - FOUNDER & CHAIRMAN of Aspen Wealth Strategies
00:10:00
Anastasia Amoroso, iCapital's Chief Investment Strategist, joins 'Closing Bell' to discuss the markets, the tech sector, and its broader economic impact.
00:10:00
Unlocking Steelport Drift: Advancing One of the World's Premier Vanadium Projects in South Africa
00:10:00
Insights into the Equities Market: Cristina S. Ulang

© 2026 Nehu